326 related articles for article (PubMed ID: 25883732)
1. Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at kidney centre in a tertiary health facility in Maiduguri, Nigeria.
Ummate I; Denue BA; Kida IM; Ohioma OJ; Baba DB; Goni W
Pan Afr Med J; 2014; 19():305. PubMed ID: 25883732
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection in chronic haemodialysis patients--relationship to blood transfusions and dialyser re-use.
Taal MW; van Zyl-Smit R
S Afr Med J; 2000 Jun; 90(6):621-5. PubMed ID: 10918894
[TBL] [Abstract][Full Text] [Related]
3. Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.
Sauné K; Kamar N; Miédougé M; Weclawiak H; Dubois M; Izopet J; Rostaing L
Nephrol Dial Transplant; 2011 Jul; 26(7):2309-16. PubMed ID: 21097646
[TBL] [Abstract][Full Text] [Related]
4. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C infection in dialysis patients in Israel.
Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of Iran.
Amiri ZM; Shakib AJ; Toorchi M
East Mediterr Health J; 2005 May; 11(3):372-6. PubMed ID: 16602456
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus-RNA, immunoglobulin M anti-HCV and risk factors in haemodialysis patients.
Dentico P; Sacco R; Buongiorno R; Volpe A; Ranieri C; Carbone M; Carabellese S
Microbios; 1999; 99(392):55-62. PubMed ID: 10624011
[TBL] [Abstract][Full Text] [Related]
8. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
Erhabor O; Ejele OA; Nwauche CA
Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
[TBL] [Abstract][Full Text] [Related]
9. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.
Yamaguchi K; Kiyokawa H; Machida J; Obayashi A; Nojiri N; Ueda S; Takatsuki K
FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and seroprevalence of hepatitis C virus antibody among blood donors in Lagos.
Balogun TM; Akinsete I; Durosinmi MA
Niger Postgrad Med J; 2012 Mar; 19(1):36-9. PubMed ID: 22430600
[TBL] [Abstract][Full Text] [Related]
11. Occasional infection of hepatitis C virus occurring in haemodialysis units identified by serial monitoring of the virus infection.
Iwasaki Y; Esumi M; Hosokawa N; Yanai M; Kawano K
J Hosp Infect; 2000 May; 45(1):54-61. PubMed ID: 10833344
[TBL] [Abstract][Full Text] [Related]
12. The role of blood transfusion on the prevalence of hepatitis C virus antibodies in children with sickle cell anaemia in Enugu, South East Nigeria.
Ejiofor OS; Ibe BC; Emodi IJ; Ikefuna AN; Ilechukwu GC; Emechebe G; Ilechukwu C
Niger J Clin Pract; 2009 Dec; 12(4):355-8. PubMed ID: 20329670
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection in patients with sickle cell anaemia at the Lagos University Hospital.
Lesi OA; Kehinde MO
Niger Postgrad Med J; 2003 Jun; 10(2):79-83. PubMed ID: 14567040
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection in renal dialysis patients in Glasgow.
McIntyre PG; McCruden EA; Dow BC; Cameron SO; McMillan MA; Allison ME; Briggs JD
Nephrol Dial Transplant; 1994; 9(3):291-5. PubMed ID: 7519762
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus infection during haemodialysis in India.
Agarwal SK; Dash SC; Irshad M
J Assoc Physicians India; 1999 Dec; 47(12):1139-43. PubMed ID: 11225211
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients.
Alavian SM; Einollahi B; Hajarizadeh B; Bakhtiari S; Nafar M; Ahrabi S
Nephrology (Carlton); 2003 Oct; 8(5):256-60. PubMed ID: 15012714
[TBL] [Abstract][Full Text] [Related]
18. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
[TBL] [Abstract][Full Text] [Related]
19. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests.
Dentico P; Volpe A; Buongiorno R; Fiore G; Carbone M; Manno C; Pastore G; Schiraldi O
Ital J Gastroenterol; 1993 Jan; 25(1):19-22. PubMed ID: 7679012
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C prevalence studied by polymerase chain reaction and serological methods in haemodialysis patients in Mazandaran, Iran.
Makhlough A; Jamshidi M; Mahdavi MR
Singapore Med J; 2008 Nov; 49(11):921-3. PubMed ID: 19037560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
